InfuSystem Holdings (INFU) EPS (Diluted) Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 95.96% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.19% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.80% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 567.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 567.39% |
| Dec 31, 2025 | 124.51% |
| Sep 30, 2025 | 30.82% |
| Jun 30, 2025 | 282.98% |
| Mar 31, 2025 | 79.87% |
| Dec 31, 2024 | 881.61% |
| Sep 30, 2024 | 148.68% |
| Jun 30, 2024 | 60.10% |
| Mar 31, 2024 | -259.57% |
| Dec 31, 2023 | -30.75% |
| Sep 30, 2023 | 60.53% |
| Jun 30, 2023 | 352.76% |
| Mar 31, 2023 | 10.15% |
| Dec 31, 2022 | -63.51% |
| Sep 30, 2022 | 194.85% |
| Jun 30, 2022 | -120.88% |
| Mar 31, 2022 | -151.51% |
| Dec 31, 2021 | -96.43% |
| Sep 30, 2021 | -116.04% |
| Jun 30, 2021 | -80.06% |